Image 1
Image 4
Image 5
Image 3
Image 2
focusing on the patient

Welcome to
OLM Innovations

OLM Innovations is committed to supporting the development of new and innovative diagnostic products with clear clinical benefits.

We will guide the process from inception to commercialisation, using our international network of specialists and decision makers in the medical sector to help give products the best possible chance of success.

Find out more about OLM innovations here.

Company News

rss_button
Journal of Infection publishes Martin Hoenigl paper
26/04/2013

Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis diagnosis in haematological malignancy and solid organ transplant patients.

Journal of Clinical Microbiology publishes Lewis White paper
26/04/2013

Evaluation of Real-Time PCR, Galactomannan Enzyme-Linked Immunosorbent Assay (ELISA), and a Novel Lateral-Flow Device for Diagnosis of Invasive Aspergillosis

Visit the news archive

Industry News

rss_button
Allicin reduces inflammation by regulating ROS/NLRP3 and autophagy in the context of A.fumigatus infection in mice.
11/08/2020

Allicin reduces inflammation by regulating ROS/NLRP3 and autophagy in the context of A.fumi

Lignin isolated from Caesalpinia pulcherrima leaves has antioxidant, antifungal and immunostimulatory activities.
11/08/2020

Lignin isolated from Caesalpinia pulcherrima leaves has antioxidant, antifungal and immunos

Cinnamyl Schiff bases: synthesis, cytotoxic effects and antifungal activity of clinical interest.
11/08/2020

Cinnamyl Schiff bases: synthesis, cytotoxic effects and antifungal activity of clinical int

Visit the news archive